Home-Based Exercise Training in Childhood-Onset Takayasu Arteritis: A Multicenter, Randomized, Controlled Trial

Camilla Astley, Gleice Clemente, Maria Teresa Terreri, Camila G Carneiro, Marcos S Lima, Carlos Alberto Buchpiguel, Hilton Leão Filho, Ana Lúcia de Sá Pinto, Clovis Artur Silva, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Saulo Gil, Rosa Maria Rodrigues Pereira, Hamilton Roschel, Bruno Gualano, Camilla Astley, Gleice Clemente, Maria Teresa Terreri, Camila G Carneiro, Marcos S Lima, Carlos Alberto Buchpiguel, Hilton Leão Filho, Ana Lúcia de Sá Pinto, Clovis Artur Silva, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Saulo Gil, Rosa Maria Rodrigues Pereira, Hamilton Roschel, Bruno Gualano

Abstract

Introduction: Childhood-onset Takayasu Arteritis (c-TA) is a rare, large-vessel vasculitis seen in children that could predisposing patients to a high risk of mortality. Exercise has the potential to improve overall health in several diseases, but evidence remains scant in c-TA. The main objective of this study was to investigate the safety and potential therapeutic effects of exercise in c-TA.

Methods: This was a 12-week, multicenter, randomized, controlled trial, to test the effects of a home-based, exercise intervention vs. standard of care in c-TA patients in remission. The primary outcomes were arterial inflammation, assessed by [18F] FDG- PET/MRI and systemic inflammatory markers. Secondary outcomes included, physical activity levels, functionality, body composition, disease-related parameters, and quality of life.

Results: Thirty-seven patients were assessed for eligibility, which represents the total number of c-TA patients being followed by the three specialized medical ambulatory services in Sao Paulo. After exclusions, fourteen c-TA patients (71.4% females) aged 12-25 years were randomly allocated into exercised (n=5) and non-exercised groups (n=9). Exercise did not exacerbate arterial inflammation. In fact, exercised patients had a reduction in the frequency of vessel segments with severe inflammation, whereas the non-exercised patients had an opposite response (P=0.007). Greater improvements in visceral fat, steps per day, functionality and physical component SF-36 were observed in the exercised patients (P ≤ 0.05).

Conclusions: Exercise is safe and may improve visceral fat, physical activity levels, functionality, and physical component SF-36 in c-TA patients. Thus, exercise arises as a novel, evidence-based intervention to improve general health in c-TA.

Clinical trial registration: https://www.clinicaltrials.gov/ct2/show/NCT03494062?term=NCT03494062&draw=2&rank=1, identifier NCT03494062.

Keywords: arterial inflammation; cardiovascular risk; physical activity; physical exercise; vasculitis

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Astley, Clemente, Terreri, Carneiro, Lima, Buchpiguel, Leão Filho, de Sá Pinto, Silva, Campos, Aikawa, Gil, Pereira, Roschel and Gualano.

Figures

Figure 1
Figure 1
Flow diagram.
Figure 2
Figure 2
Illustrative case of a 17-year-old female patient with childhood-onset Takayasu Arteritis. Left: Angioresonance of aorta and its branches after intravenous administration of gadolinium. Arrows indicates an occlusion at the third portion of the brachiocephalic trunk. Right: Arterial inflammation grade III as assessed by 18F-fluorodeoxyglucose-positron emission tomography/magnetic resonance image at the brachiocephalic trunk (SUVmax=2.38).
Figure 3
Figure 3
Panel (A): Distribution of vessel segments in grade III, representing severe inflammation. P=0.007 for between-group comparison at POST. Panel (B): Illustrative case of a 20-year-old patient with childhood-onset Takayasu Arteritis. The [18F] FDG PET/MR imaging revealed grade III inflammation in the ascending aorta artery before the intervention (SUVmax=3.41). Following the exercise training program, the uptake decreased to grade II (SUVmax=2.61).
Figure 4
Figure 4
Overview of the changes in severe arterial inflammation, visceral fat mass, IL1-β, and number of steps following a 12-week, home-based, exercise training program or control (no exercise) in c-TA patients. Noticeably, the exercise-induced amelioration in severe arterial inflammation was mirrored by decreases in visceral fat and IL-1β levels (tendency towards significance) and increases in physical activity. The hypothesis raised by this study that these responses might be interrelated should be tested by larger trials.

References

    1. Kerr GS, Hallahan CW, Giordano J, Leavitt R, Fauci AS, Rottem J, et al. . Takayasu Arteritis. Ann Intern Med (1994) 120:919–29. 10.1007/978-1-4471-4619-3_237
    1. Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Çikikçi C, Schmidt J, et al. . Assessment of the Frequency of Cardiovascular Risk Factors in Patients With Takayasu’s Arteritis. Rheumatology (United Kingdom) (2017) 56:1939–44. 10.1093/rheumatology/kex300
    1. Russo RAG, Katsicas MM. Takayasu Arteritis. Front Pediatr (2018) 6:265. 10.3389/fped.2018.00265
    1. Tripathy NK, Chauhan SK, Nityanand S. Cytokine mRNA Repertoire of Peripheral Blood Mononuclear Cells in Takayasu’s Arteritis. Clin Exp Immunol (2004) 138:369–374. 10.1111/j.1365-2249.2004.02613.x
    1. Alibaz-Oner F, Yurdakul S, Aytekin S, Direskeneli H. Impaired Endothelial Function in Patients With Takayasu’s Arteritis. Acta Cardiol (2014) 69:45–49. 10.2143/ac.69.1.3011344
    1. Yeon G, Yi S, Min S, Kyoung E, Ho S, Han H, et al. . Cardiovascular Manifestations of Takayasu Arteritis and Their Relationship to the Disease Activity: Analysis of 204 Korean Patients at a Single Center. Int J Cardiol (2012) 159:14–20. 10.1016/j.ijcard.2011.01.094
    1. Aeschlimann FA, Eng SWM, Sheikh S, Laxer RM, Hebert D, Noone D, et al. . Childhood Takayasu Arteritis: Disease Course and Response to Therapy. Arthritis Res Ther (2017) 19:1–10. 10.1186/s13075-017-1452-4
    1. Stern S, Clemente G, Reiff A, Ramos MPR, Marzan KA, Terreri MT. Treatment of Pediatric Takayasu Arteritis With Infliximab and Cyclophosphamide: Experience From an American-Brazilian Cohort Study. J Clin Rheumatol (2014) 20. 10.1097/RHU.0000000000000106
    1. Perandini LA, Sales-de-Oliveira D, Mello SBV, Camara NO, Benatti FB, Lima FR, et al. . Exercise Training can Attenuate the Inflammatory Milieu in Women With Systemic Lupus Erythematosus. J Appl Physiol (2014) 117:639–47. 10.1152/japplphysiol.00486.2014
    1. Oliveira DS, Shinjo SK, Silva MG, Sá-Pinto AL, Lima FR, Roschel H, et al. . Exercise in Takayasu Arteritis : Effects on Inflammatory and Angiogenic Factors and Disease-Related Symptoms. Arthritis Care Res (Hoboken) (2017) 69:892–902. 10.1002/acr.23011
    1. Perandini LA, de Sá-Pinto AL, Roschel H, Benatti FB, Lima FR, Bonfá E, et al. . Exercise as a Therapeutic Tool to Counteract Inflammation and Clinical Symptoms in Autoimmune Rheumatic Diseases. Autoimmun Rev (2012) 12:218–24. 10.1016/j.autrev.2012.06.007
    1. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The Anti-Inflammatory Effects of Exercise: Mechanisms and Implications for the Prevention and Treatment of Disease. Nat Rev Immunol (2011) 11:607–10. 10.1038/nri3041
    1. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. . EULAR/PRINTO/PRES Criteria for Henoch-Schonlein Purpura, Childhood Polyarteritis Nodosa, Childhood Wegener Granulomatosis and Childhood Takayasu Arteritis: Ankara 2008. Part II: Final Classification Criteria. Ann Rheum Dis (2010) 69:798–806. 10.1136/ard.2009.116657
    1. Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, et al. . Development and Initial Validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (United Kingdom) (2013) 52:1795–801. 10.1093/rheumatology/ket128
    1. Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, et al. . Disease Activity Assessment in Childhood Vasculitis: Development and Preliminary Validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis (2013) 72:1628–33. 10.1136/annrheumdis-2012-202111
    1. Behm DG, Faigenbaum AD, Falk B, Klentrou P. Canadian Society for Exercise Physiology Position Paper: Resistance Training in Children and Adolescents. Appl Physiol Nutr Metab (2008) 33:547–61. 10.1139/H08-020
    1. Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, et al. . 18F-Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis. Arthritis Rheumatol (2018) 70:439–49. 10.1002/art.40379
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem (1972) 18:499–502. 10.1177/107424840501000106
    1. Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. Accelerometer. Med Sci Sports Exerc (1998) 30:777–81. 10.1097/00005768-199805000-00021
    1. Evenson KR, Catellier DJ, Gill K, Ondrak KS, McMurray RG. Calibration of Two Objective Measures of Physical Activity for Children. J Sports Sci (2008) 26:1557–65. 10.1080/02640410802334196
    1. Newcomer KL, Krug HE, Mahowald M. Validity and Reliability of the Timed-Stands-Test for Patients With Rheumatoid Arthritis and Other Chronic Diseases. J Rheumatol (1993) 1:21–7.
    1. Podsiadlo D, Richardson S. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons. J Am Geriatr Soc (1991) 39:142–8. 10.1111/j.1532-5415.1991.tb01616.x
    1. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS, et al. . Development and Initial Validation of the Vasculitis Damage Index for the Standardized Clinical Assessment of Damage in the Systemic Vasculitides. Arthritis Rheum (1997) 40:371–80. 10.1002/art.1780400222
    1. Ferraz MB. Crosscultural Reliability of the Physical Ability Dimension of the Health Assessment Questionnaire. J Rheumatol (1990) 17:813–817.
    1. Bacchetti P. Current Sample Size Conventions: Flaws, Harms, and Alternatives. BMC Med (2010) 8:1–7. 10.1186/1741-7015-8-17
    1. Prado DML, Benatti FB, de Sá-Pinto AL, Hayashi AP, Gualano B, Pereira RMR, et al. . Exercise Training in Childhood-Onset Systemic Lupus Erythematosus: A Controlled Randomized Trial. Arthritis Res Ther (2013) 15:1–11. 10.1186/ar4205
    1. Takken T, van der Net J, Helders PJM. Anaerobic Exercise Capacity in Patients With Juvenile-Onset Idiopathic Inflammatory Myopathies. Arthritis Care Res (2005) 53:173–7. 10.1002/art.21066
    1. Gualano B, Bonfa E, Pereira RMR, Silva CA. Physical Activity for Paediatric Rheumatic Diseases : Standing Up Against Old Paradigms. Nat Publ Gr (2017) 13:368–79. 10.1038/nrrheum.2017.75
    1. Walter MA, Melzer RA, Schindler C, Mu J, Tyndall A, Nitzsche EU. Vasculitis and the Assessment of Activity and Extent of Disease. Eur J Nucl Med Mol Imaging (2005) 32:647–81. 10.1007/s00259-004-1757-9
    1. Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, et al. . Aortic Wall Inflammation Due to Takayasu Arteritis Imaged With 18F-FDG PET Coregistered With Enhanced CT. J Nucl Med (2005) 46.
    1. Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki JI, et al. . Role of FDG PET-CT in Takayasu Arteritis: Sensitive Detection of Recurrences. JACC Cardiovasc Imaging (2012) 5:422–9. 10.1016/j.jcmg.2012.01.013
    1. Wedell-Neergaard AS, Eriksen L, Grønbæk M, Pedersen BK, Krogh-Madsen R, Tolstrup J. Low Fitness Is Associated With Abdominal Adiposity and Low-Grade Inflammation Independent of BMI. PloS One (2018) 13:1–11. 10.1371/journal.pone.0190645
    1. Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, et al. . Muscle-Derived Interleukin-6: Lipolytic, Anti-Inflammatory and Immune Regulatory Effects. Pflugers Arch (2003) 446:9–16. 10.1007/s00424-002-0981-z

Source: PubMed

Подписаться